Suppression of Epidermal Growth Factor Receptor by Erlotinib Attenuates Carvacrol-induced Skin Inflammation
Epidermal growth factor receptors (EGFRs) regulate the growth and repair process of epithelia, as well as carcinogenesis. Activation of TRPV3 by carvacrol stimulates skin inflammation and epidermal hyperplasia; the latter can be suppressed by EGFR inhibition. However, whether EGFR signalling is resp...
Saved in:
| Main Authors: | Yujing Wang, Wenjie Huang, Haidong Jia, Qinglian Tang, Qingfei Yin, Yuanyuan Chen, Wumei Wang, Zhengyu Cao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Journals Sweden
2024-12-01
|
| Series: | Acta Dermato-Venereologica |
| Subjects: | |
| Online Access: | https://medicaljournalssweden.se/actadv/article/view/40975 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erlotinib Improves the Response of Glioblastoma Cells Resistant to Photodynamic Therapy
by: Karen Olthoff, et al.
Published: (2024-11-01) -
Upregulated interleukin‐6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma
by: Aditya Stanam, et al.
Published: (2015-08-01) -
Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review)
by: O.M. Smorodska, et al.
Published: (2021-06-01) -
Carvacrol attenuates N-nitrosodiethylamine induced liver injury in experimental Wistar rats
by: Balan Rajan, et al.
Published: (2015-06-01) -
Carvacrol attenuated haloperidol-induced Parkinson’s disease via TNF/NFκβ-NLRP3-mediated pyroptosis
by: Faisal Albaqami, et al.
Published: (2025-02-01)